CliffBio
small molecule

ILUVIEN

FLUOCINOLONE ACETONIDE

Loss of exclusivityNovember 2028latest FDA-listed patent expiry
CompanyAlimera Sciences →View the full company profile on CliffBio

Drug detail

Brand nameILUVIEN
Active ingredientFLUOCINOLONE ACETONIDE
Strength0.19MG
Dosage formIMPLANT
RouteINTRAVITREAL
ModalitySmall molecule
FDA approvalSeptember 2014
Marketing statusRX

Listed patents

PatentExpiresType
9849027November 2028product
8871241August 2027product

More from Alimera Sciences

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ILUVIEN patent cliff — loss of exclusivity November 2028 | CliffBio